Arkolith/Insider Trading/LEXX/Form 4

Turkel Catherine C.

DirectorLexaria Bioscience Corp. (LEXX) · full profile →Form 4 · filed Aug 13, 2024
Net Buying
Open-Market Buys
$5K
Open-Market Sells
$0
Net Open-Market Flow
$5K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 12, 2024Buy(P)2K$3.13$5K3K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001855763-24-000013) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML